[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568099":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":52,"collaborators":18,"id":54,"slug":18,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":18,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":18,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":33,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Institute of Liver and Biliary Sciences, India","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ADF","EXPERIMENTAL","Experimental: Alternate day fasting, along with standard medical management.",[13],"Behavioral: Alternate day fasting",{"label":15,"type":16,"description":17,"interventionNames":18},"Control arm","NO_INTERVENTION","Standard medical management.",null,[20],{"type":21,"name":22,"description":22,"armGroupLabels":23,"otherNames":18},"BEHAVIORAL","Alternate day fasting",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Babu Lal Meena, DM Hepatology","CONTACT","+91-9781100898","drbabupgi@gmail.com",[31],{"facility":32,"status":33,"city":34,"state":18,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Institute of Liver and Biliary Sciences","RECRUITING","Delhi","110070","India","IN",{"type":39,"coordinates":40},"Point",[41,42],77.23149,28.65195,{"lat":42,"lon":41},[45,47,49],{"name":46,"role":27,"phone":28,"phoneExt":18,"email":29},"Dr Babu Lal Meena, DM Hepatology",{"name":26,"role":48,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"name":50,"role":51,"phone":18,"phoneExt":18,"email":18},"Shiv Kumar Sarin, DM, DSC(Hony)","SUB_INVESTIGATOR",{"type":53,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100568099",false,"NCT06676813","Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.","Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis(NASH), A Randomized Controlled Trial. FAST Trial\"","Inclusion Criteria:\n\n* Age 18-65 years. BMI 25-40kg\u002Fm3, and CAP more than 290\n* Stable weight in the last 3 months prior to enrolling in the study(\\\u003C5kg weight variation)\n* Imaging showed steatotic liver disease, liver stiffness \\\u003C14kPa measured by fibroscan\n* Histologically proven NASH\u002FMASH, fibrosis up to F3\n* Subjects willing to participate in the study\n\nExclusion Criter\n\n* Liver stiffness \\>14kPa measured by fibroscan or Fibrosis \\>F3\n* Diabetes with HbA1c\\>8.5%\n* Patients with another co-existing active liver disease e.g. hepatitis B or C, alcoholic liver disease\n* Patients with cirrhosis, hepatocellular carcinoma(HCC), or other malignancy\n* Chronic kidney disease, cardiovascular disorders, uncontrolled hypertension\n* Chronic infections, chronic inflammatory diseases\n* Patients on weight loss medications e.g semaglutide\n* Pregnant or lactating women and those planning a pregnancy A patient who is not willing to participate in the study or failed to provide the consent","ALL","18 Years","65 Years",{"count":64,"type":65},72,"ESTIMATED","INTERVENTIONAL",[68],"NA","The aims of this study are as follows: To compare the role of alternate-day fasting over standard medical management alone to reverse NASH.",[71],"Non Alcoholic Steatohepatitis",[73,74,75,76,77],"Alternate day fasting.","NASH","MASH","Steatotic liver disease","Cirrhosis","2024-11-05",{"date":80,"type":81},"2024-11-07","ACTUAL",{"date":83,"type":81},"2024-07-01",{"date":85,"type":65},"2025-06-30",{"name":5,"class":6},1]